Altimmune announces manufacturing agreement with vigene biosciences for adcovid

Altimmune announces manufacturing agreement with vigene biosciences for adcovid™, its single dose intranasal vaccine candidate for covid-19.altimmune inc - altimmune plans to start a phase 1 clinical trial of adcovid in q4 2020..altimmune inc - initiating scale up of manufacturing of adcovid vaccine for advanced clinical trials and commercial production.altimmune - engaged in discussions with strategic manufacturing partners with goal of producing at least 100 million doses of adcovid in 2021.
ALT Ratings Summary
ALT Quant Ranking